Tradjenta Interactions
There are 347 drugs known to interact with Tradjenta (linagliptin), along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 2 are major, 344 are moderate, and 1 is minor.
- View all 347 medications that may interact with Tradjenta
- View Tradjenta alcohol/food interactions (1)
- View Tradjenta disease interactions (1)
Most frequently checked interactions
View interaction reports for Tradjenta (linagliptin) and the medicines listed below.
- allopurinol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- carvedilol
- Crestor (rosuvastatin)
- furosemide
- gabapentin
- glimepiride
- glipizide
- hydrochlorothiazide
- Jardiance (empagliflozin)
- levothyroxine
- lisinopril
- losartan
- metformin
- metoprolol
- Metoprolol Succinate ER (metoprolol)
- omeprazole
- pantoprazole
- potassium chloride
- prednisone
- rosuvastatin
- simvastatin
- spironolactone
- tamsulosin
- tramadol
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Tradjenta alcohol/food interactions
There is 1 alcohol/food interaction with Tradjenta (linagliptin).
Tradjenta disease interactions
There is 1 disease interaction with Tradjenta (linagliptin) which include:
Report options
QR code containing a link to this page
More about Tradjenta (linagliptin)
- Tradjenta consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (74)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: dipeptidyl peptidase 4 inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
